Pedro Such

7PUBLICATIONS
20CO-AUTHORS
Behavioural epidemiologyEpidemiological methodsPsychology of ageingInstrumental methods (excl. immunological and bioassay methods)Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 29, 2026
Brexpiprazole for Agitation in Patients with Alzheimer's Dementia with and without Co-Occurring Psychosis: Post Hoc Analysis of Short- and Long-Term Trials.

|Jan 27, 2026
Efficacy of Brexpiprazole in Participants with Agitation Associated with Dementia Due to Alzheimer's Disease: Pooled Analysis of Randomized Controlled Trials.

Jeffrey L Cummings, Sanjeda R Chumki, Denise Chang

|Jul 18, 2025
Safety and Tolerability of Brexpiprazole in Participants with Agitation Associated with Dementia due to Alzheimer's Disease: Pooled Analysis of Three Randomized Trials and an Extension Trial.

Alpesh Shah, Alvin Estilo, Pamela L Sheridan

|Jun 14, 2023
Aripiprazole Plasma Concentrations Delivered from Two 2-Month Long-Acting Injectable Formulations: An Indirect Comparison.

Matthew Harlin, Craig Chepke, Frank Larsen

|Jun 05, 2023
Safety and efficacy of aripiprazole 2-month ready-to-use 960 mg: secondary analysis of outcomes in adult patients with bipolar I disorder in a randomized, open-label, parallel-arm, pivotal study.

Roger S McIntyre, Pedro Such, Murat Yildirim

|Mar 24, 2023
A Randomized, Open-Label, Multiple-Dose, Parallel-Arm, Pivotal Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole 2-Month Long-Acting Injectable in Adults With Schizophrenia or Bipolar I Disorder.

Matthew Harlin, Murat Yildirim, Pedro Such

Pageof 2

Frequent Collaborators

3 joint publications

Matthew Harlin

3 joint publications

Murat Yildirim

3 joint publications

Jessica Madera-McDonough

3 joint publications

Frank Larsen